ASP Isotopes (ASPI) financial statements
ASP Isotopes reported revenue of $24M in fiscal 2025, up 642.1% a year over 2 years.
Net income was -$160M.
Free cash flow was -$47M.
The diluted share count rose 210% over the period (dilution).
Revenue and free cash flow
Fiscal years, $ billions.
Income statement
Fiscal years, from ASP Isotopes's 10-K filings with the SEC.
| Fiscal year | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Revenue | $0 | $433,026 | $4M | $24M |
| Cost of revenue | $0 | $294,056 | $3M | $20M |
| Gross profit | $0 | $138,970 | $2M | $3M |
| Research and development | $1M | $764,581 | $3M | $12M |
| Selling, general and admin | $4M | $15M | $25M | $48M |
| Operating income | -$5M | -$16M | -$26M | -$60M |
| Interest expense | $0 | $118,547 | $259,000 | $575,000 |
| Pre-tax income | -$5M | -$16M | -$32M | -$160M |
| Income tax | $0 | -$6,133 | $111,000 | $282,000 |
| Net income | -$5M | -$16M | -$32M | -$160M |
| EPS (diluted) | -$0.18 | -$0.49 | -$0.63 | -$2.11 |
| Diluted shares | 27M | 33M | 56M | 83M |
| Gross margin | — | 32.1% | 38.6% | 14.3% |
| Operating margin | — | -3704.6% | -636.0% | -251.2% |
| Net margin | — | -3762.9% | -782.4% | -670.2% |
Balance sheet
Fiscal years, from ASP Isotopes's 10-K filings with the SEC.
| Fiscal year | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Cash and short-term investments | $2M | $8M | $62M | $327M |
| Receivables | $0 | $216,504 | — | — |
| Inventory | — | $0 | $66,000 | $1M |
| Total current assets | $3M | $11M | $66M | $400M |
| Property, plant and equipment | $8M | $11M | $22M | $33M |
| Goodwill | $0 | $3M | $3M | $5M |
| Total assets | $12M | $28M | $94M | $498M |
| Total current liabilities | $2M | $6M | $7M | $33M |
| Long-term debt | — | — | $1M | $1M |
| Total liabilities | $3M | $9M | $43M | $235M |
| Shareholders' equity | $10M | $16M | $48M | $204M |
| Net debt | -$2M | -$8M | -$60M | -$278M |
Cash flow
Fiscal years, from ASP Isotopes's 10-K filings with the SEC.
| Fiscal year | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Operating cash flow | -$3M | -$5M | -$17M | -$38M |
| Capital spending | $4M | $2M | $10M | $10M |
| Free cash flow | -$7M | -$8M | -$26M | -$47M |
| Stock-based compensation | $2M | $9M | $9M | $16M |
| Dividends paid | — | $0 | $3M | $0 |
| Net borrowing | $0 | $526,282 | -$111,000 | -$252,000 |
| Free cash flow margin | — | -1788.3% | -636.4% | -198.9% |
| Dividends per share | — | — | $0.05 | — |
Every line, every quarterThe deep dive has fifteen-plus years of statements, quarterly results, charts and valuation models for ASPI.
Open ASPI in InvestinglyQuestions
What was ASP Isotopes's revenue in 2025?
$24M in fiscal 2025, from its 10-K filing.
How much free cash flow does ASP Isotopes generate?
-$47M in fiscal 2025 (operating cash flow minus capital spending).
From ASP Isotopes's annual reports filed with the SEC (XBRL data), standardised by Investingly. Information only, not investment advice.